KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Net Margin (2016 - 2025)

Charles River Laboratories International has reported Net Margin over the past 16 years, most recently at 27.82% for Q4 2025.

  • Quarterly results put Net Margin at 27.82% for Q4 2025, down 630.0% from a year ago — trailing twelve months through Dec 2025 was 3.59% (down 385.0% YoY), and the annual figure for FY2025 was 3.59%, down 385.0%.
  • Net Margin for Q4 2025 was 27.82% at Charles River Laboratories International, down from 5.42% in the prior quarter.
  • Over the last five years, Net Margin for CRL hit a ceiling of 18.46% in Q4 2023 and a floor of 27.82% in Q4 2025.
  • Median Net Margin over the past 5 years was 8.96% (2023), compared with a mean of 6.29%.
  • Biggest five-year swings in Net Margin: skyrocketed 267bps in 2022 and later crashed -3997bps in 2024.
  • Charles River Laboratories International's Net Margin stood at 15.45% in 2021, then increased by 11bps to 17.19% in 2022, then grew by 7bps to 18.46% in 2023, then tumbled by -217bps to 21.52% in 2024, then fell by -29bps to 27.82% in 2025.
  • The last three reported values for Net Margin were 27.82% (Q4 2025), 5.42% (Q3 2025), and 5.07% (Q2 2025) per Business Quant data.